OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 141 filers reported holding OCULAR THERAPEUTIX INC in Q3 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,146,000 | -23.2% | 517,133 | -25.6% | 0.79% | -29.6% |
| Q2 2022 | $2,794,000 | -18.8% | 695,000 | 0.0% | 1.12% | -2.9% |
| Q1 2022 | $3,440,000 | -29.0% | 695,000 | 0.0% | 1.15% | -13.8% |
| Q4 2021 | $4,844,000 | -12.9% | 695,000 | +25.0% | 1.34% | -8.4% |
| Q3 2021 | $5,560,000 | +53.1% | 556,000 | +117.1% | 1.46% | +73.2% |
| Q2 2021 | $3,632,000 | -31.6% | 256,152 | -21.5% | 0.84% | -42.9% |
| Q1 2021 | $5,313,000 | -15.3% | 326,174 | +7.6% | 1.48% | -37.0% |
| Q4 2020 | $6,276,000 | – | 303,174 | – | 2.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,932,607 | $40,643,000 | 15.56% |
| Lamond Capital Partners LLC | 711,533 | $14,964,000 | 15.19% |
| Polaris Venture Management Co. V, L.L.C. | 1,230,009 | $25,867,000 | 11.54% |
| NOTTINGHAM ADVISORS, INC. | 171,985 | $3,617,000 | 0.60% |
| Portolan Capital Management | 122,518 | $2,577,000 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 160,000 | $3,365,000 | 0.33% |
| Rotella Capital Management, Inc. | 18,461 | $388,000 | 0.32% |
| Monashee Investment Management LLC | 28,834 | $606,000 | 0.29% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 335,498 | $7,056,000 | 0.24% |
| BAILARD, INC. | 55,000 | $1,157,000 | 0.18% |